Free Trial

Atara Biotherapeutics (ATRA) SEC Filings & 10K Form

$0.59
+0.03 (+5.57%)
(As of 12:03 PM ET)

Recent Atara Biotherapeutics SEC Filings

DateFilerForm TypeView
05/22/2024
5:18 PM
Adiumentum Capital Fund I LP (Filed by)
Atara Biotherapeutics (Subject)
Form SC 13D
05/20/2024
7:32 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:33 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:33 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:34 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:34 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
8:13 PM
Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
8:13 PM
Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
8:14 PM
Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
8:14 PM
Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
8:15 PM
Atara Biotherapeutics (Subject)
Touchon Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
7:55 PM
Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/26/2024
3:20 PM
Atara Biotherapeutics (Filer)
Form DEFA14A
04/26/2024
3:15 PM
Atara Biotherapeutics (Filer)
Form DEF 14A
04/12/2024
3:15 PM
Atara Biotherapeutics (Filer)
Atara Biotherapeutics (Filer)
Form PRE 14A
04/02/2024
5:11 PM
Atara Biotherapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:12 PM
Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:12 PM
Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:12 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
5:13 PM
Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:30 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
7:40 AM
Atara Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:35 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
5:18 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:18 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:19 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:16 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:17 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
7:17 PM
Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:18 PM
Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:19 PM
Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:21 PM
Atara Biotherapeutics (Subject)
Touchon Pascal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:13 PM
Atara Biotherapeutics (Subject)
Nguyen Tran (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
3:30 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
3:45 PM
Atara Biotherapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G/A
01/22/2024
12:58 PM
Atara Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/09/2024
3:40 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:40 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:40 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:40 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:41 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
[Urgent!] Generational Wealth Gameplan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide
01/09/2024
3:28 PM
Atara Biotherapeutics (Filer)
Form 424B5
01/09/2024
3:22 PM
Atara Biotherapeutics (Subject)
BAUPOST GROUP LLC/MA (Filed by)
Form SC 13G/A
01/08/2024
7:11 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
3:30 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
1:45 PM
Atara Biotherapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
11/20/2023
4:31 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:31 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:29 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:29 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:30 PM
Atara Biotherapeutics (Issuer)
Joshi Manher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
4:30 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
3:31 PM
Atara Biotherapeutics (Filer)
Form 424B3
11/14/2023
5:27 PM
Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
5:29 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
11:15 PM
Atara Biotherapeutics (Filer)
Form EFFECT
11/08/2023
8:16 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
4:25 PM
Atara Biotherapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/01/2023
7:35 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
7:40 AM
Atara Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Joshi Manher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
5:25 PM
Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2023
3:15 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
7:06 PM
Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:08 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:09 PM
Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:09 PM
Atara Biotherapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:09 PM
Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:09 PM
Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:09 PM
Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ATRA) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners